Related references
Note: Only part of the references are listed.Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series
Mattia Fonderico et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis
Tomas Uher et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Neurofilament light levels are associated with long-term outcomes in multiple sclerosis
Jens Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Intrathecal IgM as a Prognostic Marker in Multiple Sclerosis
Mia Topsoe Mailand et al.
MOLECULAR DIAGNOSIS & THERAPY (2020)
Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis
Finn Sellebjerg et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies
Sarah-Jane Martin et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis
Lorenzo Gaetani et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
CSF parameters associated with early MRI activity in patients with MS
Ana Klein et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis
Catherina Pfuhl et al.
NEUROLOGY (2019)
Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis
Sara Gil-Perotin et al.
FRONTIERS IN NEUROLOGY (2019)
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?
Jessica Frau et al.
JOURNAL OF NEUROLOGY (2018)
Intrathecal immunoglobulin M production: A promising high-risk marker in clinically isolated syndrome patients
Andre Huss et al.
ANNALS OF NEUROLOGY (2018)
Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis
Irene Hakansson et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results
Serkan Ozakbas et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2017)
Optimizing treatment success in multiple sclerosis
Tjalf Ziemssen et al.
JOURNAL OF NEUROLOGY (2016)
Intrathecal lipid-specific oligoclonal IgM synthesis associates with retinal axonal loss in multiple sclerosis
Jose C. Alvarez-Cermeno et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
The APOSTEL recommendations for reporting quantitative optical coherence tomography studies
Andres Cruz-Herranz et al.
NEUROLOGY (2016)
Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice
M. Espino et al.
CLINICA CHIMICA ACTA (2015)
Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis
L. M. Villar et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual
Laurence Durante et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Quantitative MRI and Cerebrospinal Fluid Inflammatory Mediators in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis before and after Treatment with Immunomodulators: A Longitudinal Study
Heloisa H. Ruocco et al.
NEUROIMMUNOMODULATION (2012)
Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes
Maria Jose Magraner et al.
NEURORADIOLOGY (2012)
The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment
Prejaas Tewarie et al.
PLOS ONE (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis
Emma C. Tallantyre et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
A multifactorial prognostic index in multiple sclerosis - Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease
Jessica Mandrioli et al.
JOURNAL OF NEUROLOGY (2008)
Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis
M. Thangarajh et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Antibody structure, instability, and formulation
Wei Wang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Cerebrospinal fluid IgM index correlates with cranial MRI lesion load in patients with multiple sclerosis
Peter J. H. Jongen et al.
EUROPEAN NEUROLOGY (2007)
Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis
P. Perini et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS
LM Villar et al.
NEUROLOGY (2002)
A sensitive and reproducible method for the detection of oligoclonal IgM bands
LM Villar et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Share Paper
